Article info

Download PDFPDF
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Authors

  1. Correspondence to:
    Dr M E Farkouh
    Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1074, New York, New York 10029, USA; michael.farkouh{at}mssm.edu
View Full Text

Citation

Farkouh ME, Greenberg JD, Jeger RV, et al
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Publication history

  • Accepted January 21, 2007
  • First published April 5, 2007.
Online issue publication 
May 18, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.